Rocket Pharmaceuticals, Inc. (RCKT)
3.63
+0.27
(+8.04%)
USD |
NASDAQ |
Dec 10, 16:00
3.64
+0.01
(+0.28%)
After-Hours: 20:00
Rocket Pharmaceuticals EPS Diluted (Quarterly): -0.4511 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Merck & Co., Inc. | 2.316 |
| Avalo Therapeutics, Inc. | -2.187 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.33M |
| Total Expenses (Quarterly) | 50.33M |
| Enterprise Value | 195.13M |
| Earnings Yield | -61.92% |
| Normalized Earnings Yield | -61.29 |